Maternal Health Care / Hypertensive Disorder of Pregnancy / Connected MOM + · Interventional Study

Implementation Models for Blood Pressure Monitoring in Pregnancy and Postpartum: Connected MOM Plus

ClinicalTrials.gov · September 3, 2026

Preliminary Why this matters to you Expert discussion

Early or partial results. Treat as a signal, not a conclusion.

AI Summary

This is a registry record for a planned quality improvement study evaluating Connected MOM Plus, a blood pressure monitoring intervention for pregnant and postpartum individuals. No results are posted in this registry entry; the study is currently recruiting and designed to measure uptake, blood pressure control, and maternal composite outcomes at 6–9 months. Clinicians and researchers should note that no efficacy or safety data are available from this record alone.

What was studied

Interventional, Randomized, Parallel, Single masking, Health Services Research purpose. Maternal Health Care, Hypertensive Disorder of Pregnancy; Female; age from 18 Years; to 80 Years. Intervention: Intervention - CM+. Compared with: Control - CM — No Intervention. n = 2,000. 1 site: United States.

Key findings

Safety

This is a registry record with no results posted; no efficacy, safety, or outcome data are available.

Who this may help

No clinical impact can be assessed from a registry record without results. Once results are posted, clinicians should evaluate whether Connected MOM Plus improves uptake of blood pressure monitoring and whether it reduces maternal adverse outcomes in underserved populations.

Plain-language summary

This is a clinical trial registry record describing a planned quality improvement study with no results posted; it establishes the design and primary outcomes but carries no evidence of efficacy or safety.

Study design

As stated by the source record.

MethodsPrimary outcome measures: Successful use of the intervention and control programs measured by enrollment aggregate (assessed at 6-9 months); Successful use of the intervention and control programs as determined by the systolic and diastolic blood pressure measurements (assessed at 6-9 months); Successful use of the intervention and control programs as determined by postpartum blood pressure measurement (assessed at 6-9 months); Adequacy of prenatal care (assessed at 6-9 months); Adverse composite maternal outcome (assessed at 6-9 months)

DesignInterventional, Randomized, Parallel, Single masking, Health Services Research purpose

PopulationMaternal Health Care, Hypertensive Disorder of Pregnancy; Female; age from 18 Years; to 80 Years

Sample size2,000

InterventionIntervention - CM+

ComparatorControl - CM — No Intervention

Setting1 site: United States

Reported figures

Quoted from the source exactly as published.

Planned enrollment2000

Primary outcome measure 1Successful use of intervention and control programs measured by enrollment aggregate, 6–9 months

Primary outcome measure 2Successful use of intervention and control programs as determined by systolic and diastolic blood pressure measurements, 6–9 months

Primary outcome measure 3Successful use of intervention and control programs as determined by postpartum blood pressure measurement, 6–9 months

Primary outcome measure 4Adequacy of prenatal care, 6–9 months

Primary outcome measure 5Adverse composite maternal outcome, 6–9 months

Clinical bottom line

Caveats

This is a registry record with no results posted; no efficacy, safety, or outcome data are available.
No randomization, blinding, or control group design described in this registry entry.
Comparator arm definition and allocation method not stated.
Follow-up duration and study completion status not provided in this record.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

limited

Quality improvement initiative; phase not specified; no randomization described.

Directness

moderate

Primary outcomes include blood pressure measurement and maternal composite outcome.

Consistency

insufficient

Registry record; no results reported; consistency cannot be assessed.

Risk of bias

insufficient

No methodological detail on blinding, allocation, or comparator group disclosed.

Sample adequacy

moderate

Planned enrollment 2000 participants; sample size adequate for QI outcome measurement.

What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.

Source abstract

Registry record from ClinicalTrials.gov (NCT07691541). This is a study registration, not published results. Lead sponsor: Tulane University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 2000 participants (ESTIMATED). Conditions: Maternal Health Care, Hypertensive Disorder of Pregnancy. Interventions: OTHER: Connected MOM +. Primary outcome measures: Successful use of the intervention and control programs measured by enrollment aggregate , 6-9 months; Successful use of the intervention and control programs as determined by the systolic and diastolic blood pressure measurements , 6-9 months; Successful use of the intervention and control programs as determined by postpartum blood pressure measurement , 6-9 months; Adequacy of prenatal care , 6-9 months; Adverse composite maternal outcome , 6-9 months. Brief summary: Quality improvement (QI) initiative to improve uptake and utilization of Connected MOM, particularly among those with limited access to health care

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

Maternal Health CareHypertensive Disorder of PregnancyNCT07691541Connected MOM +Tulane University